A Compliance-Aware Approach to Building a Kids Range

A kids-positioned supplement range answers to a different, and generally stricter, set of expectations than an adult range aimed at the same category — daily vitamins, a single-nutrient story, a beauty-from-within angle. The audience is a parent making a purchase decision on behalf of a child, which means the copy, the format and the framing all carry more scrutiny than the equivalent adult SKU would.

Brand owners entering the kids category for the first time sometimes assume the difference is cosmetic — a brighter label, a kid-friendly flavour, a smaller pack size — and treat the underlying claim and positioning work exactly as they would for an adult range. That assumption is a common source of avoidable rework on a kids launch, because claim language that reads as routine on an adult product reads as a much bigger promise on a children's one.

The doctrine that should sit behind every kids-range decision, from concept through artwork, is claim-sensitivity: at every stage, ask whether the current copy, format or positioning choice makes an outcome promise the finished product cannot stand behind, and default to the more cautious option whenever the answer is unclear.

That default should sit with whoever signs off copy and artwork on the brand side, not only with whoever reviews the finished pack right before print. A claim-sensitive doctrine applied only at the final review catches fewer problems than the same doctrine applied at the concept stage, before an outcome-led idea has already shaped the name, the artwork brief and the positioning a parent will read on shelf.

The safer way to position a kids SKU is around a nutrient story or a daily-routine occasion, rather than around an outcome a parent is meant to expect. "A daily multivitamin gummy for kids" or "a vitamin C gummy for kids" describes what is in the product and who it is for without promising what will happen after a child takes it, which keeps the positioning inside claim-sensitive bounds without needing to soften an outcome claim after the fact.

This is a genuine constraint on copy, not just a formality: a kids range that leans on outcome language in its early positioning work tends to need that language rewritten later once the claim review catches it, which is slower and more expensive than writing to the cautious standard from the brief stage. No efficacy or health-outcome claim belongs anywhere in kids-range copy, on pack or off it.

A useful discipline is to write the kids-range positioning as a nutrient-and-occasion statement first, and only afterward ask whether anything more persuasive could be added, rather than starting from the most persuasive possible claim and trying to walk it back to something defensible. The second approach is where most claim-review rework comes from.

Gummies are the format brand owners choose by default for a kids range, and for good reason: the format is familiar to parents and children alike, travels well through the private label programme, and does not carry the same dose-format mismatch risk that some novel delivery formats do for a younger audience.

Other formats reviewed elsewhere in the catalogue — a sachet, an oral strip — are evaluated case by case for a kids range rather than treated as a default option, because format suitability for a child audience depends on considerations, such as piece size and packaging a child should not be able to open unassisted, that a format built primarily for an adult audience was not necessarily reviewed against.

A brand owner considering a format other than the gummy default for a kids SKU should raise that at the brief stage rather than assuming it will be a straightforward substitution, so DAT can confirm feasibility against the child-audience considerations before any specification work begins.

Pack size and count also deserve more attention on a kids SKU than the equivalent adult product, since a parent buying on behalf of a child is often weighing portion control and household use in a way a single adult buyer is not. That framing belongs in the brief stage alongside the format decision, not as an afterthought once the format is already locked.

Documentation is released by order stage; the batch-specific Certificate of Analysis is issued after production and quality-control release, and the brand owner remains responsible for compliance on the finished product. The private label option starts from 1,000 units for a standard PET bottle, or 2,500 units for doypack packaging, and that commitment does not change because the audience is younger — the same tiers apply to a kids SKU as to any other private label product.

For a kids range, the division of responsibility is worth understanding clearly before the brief goes in: the manufacturer's documentation confirms what was produced and to what specification, not what claim language a brand is entitled to use on pack.

A brand owner should not read a clean specification confirmation or a passed batch release as clearance for a stronger claim than the one reviewed at the brief stage. Production documentation and claim approval are related but not the same, and treating a production sign-off as a claims sign-off is a common and avoidable confusion on a kids launch.

Where a brand plans to make any claim about a kids SKU beyond a basic nutrient-and-occasion description, that claim review sits with the brand's own regulatory or legal advisor for the destination market, not with the manufacturing documentation path — the two review processes run in parallel and should not be assumed to cover each other.

The brand owner remains responsible for compliance on a kids-positioned SKU in the same way as on any other product carrying their name — the manufacturer confirms specification, artwork alignment with what the brief describes, and batch release; the brand confirms that the finished pack, once labelled and marketed, meets the destination market's rules for a children's product and for any claim the brand chooses to make.

This ownership split is worth stating plainly to anyone inside the brand's own organisation who assumes "the manufacturer handles compliance" as a blanket reassurance. On a kids range specifically, where the review bar for claims and labelling is generally stricter than for an adult product, a brand that has not confirmed its own compliance ownership before launch is exposed in a way that a clean specification confirmation does not protect against.

A kids range planned with this ownership split understood from the brief stage, rather than discovered after the first batch ships, moves through the standard documentation-by-stage path — specification, artwork review, batch release — the same way any other SKU does, with the brand's own compliance review running alongside it rather than being assumed away.

Make it Yours changes flavour, colour or shape on an existing formula; naming and artwork still follow the standard private label branding process. Inside a kids range, this scope supports genuine variety — different flavours or colours across a small family of kids SKUs — without opening a new formula review for each variant, which keeps a kids range's claim-sensitivity review concentrated on one base formula rather than spread across several.

The same caution about outcome claims applies to every Make it Yours variant, not only to the anchor SKU: a flavour change does not change what the product can claim to do, and copy for a second or third kids variant should be reviewed against the same claim-sensitive standard as the first, not assumed to inherit a lighter review because the base formula already cleared.

Brand owners building a small kids family — a daily multivitamin gummy alongside a single-nutrient variant, for instance — through Make it Yours on one base formula tend to move faster and with fewer claim-review surprises than brands that brief each kids variant as a separate concept from the start.

A reliable discipline for a kids range is to review every SKU against the same claim-sensitive bar before it goes to artwork, rather than reviewing the first SKU carefully and assuming later additions inherit that same scrutiny automatically. A range that stays claim-safe across its first SKU and then drifts on its third is a slower problem to catch than one reviewed consistently from the start.

That discipline extends to every future addition to the range, not just the opening SKUs: a kids range that grows well is one where every new flavour, format question or positioning idea is measured against the same no-efficacy-claim standard the first SKU was built to, rather than a standard that quietly loosens as the range grows and confidence builds.

Start a range planning brief and DAT will review the format choice, the private label catalogue programme and the documentation-by-stage path for a kids range together, so claim-sensitivity is built into the plan from the first SKU rather than checked at the end.